Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity

International Classification of Retinopathy of Prematurity, Third Edition

(2021) Michael F. Chiang et al.   OPHTHALMOLOGY

Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial

(2019) Andreas Stahl et al.   LANCET

Development of refractive error in children treated for retinopathy of prematurity with anti-vascular endothelial growth factor (anti-VEGF) agents: A meta-analysis and systematic review

(2019) Qing-Qing Tan et al.   PLoS One

Comparison of clinical outcomes of intravitreal ranibizumab and aflibercept treatment for retinopathy of prematurity

(2018) Emine Alyamaç Sukgen et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Screening Examination of Premature Infants for Retinopathy of Prematurity

(2018) Walter M. Fierson et al.   PEDIATRICS

Development of a Retinopathy of Prematurity Activity Scale and Clinical Outcome Measures for Use in Clinical Trials

(2018) Lois E. H. Smith et al.   JAMA Ophthalmology

Changes in systemic vascular endothelial growth factor levels after intravitreal injection of aflibercept in infants with retinopathy of prematurity

(2017) Chung-Ying Huang et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Very Late Reactivation of Retinopathy of Prematurity After Monotherapy With Intravitreal Bevacizumab

(2016) Laura L. Snyder et al.   Ophthalmic Surgery Lasers & Imaging Retina

REACTIVATION OF RETINOPATHY OF PREMATURITY AFTER RANIBIZUMAB TREATMENT

(2015) Ryan K. Wong et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Structural, Visual and Refractive Outcomes of Intravitreal Aflibercept Injection in High-Risk Prethreshold Type 1 Retinopathy of Prematurity

(2014) Abdelrahman G. Salman et al.   OPHTHALMIC RESEARCH

Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010

(2013) Hannah Blencowe et al.   PEDIATRIC RESEARCH

Reactivation of Retinopathy of Prematurity After Bevacizumab Injection

(2012) Jennifer Hu et al.   ARCHIVES OF OPHTHALMOLOGY

Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity

(2011) Helen A. Mintz-Hittner et al.   NEW ENGLAND JOURNAL OF MEDICINE